Pharmacokinetic characterization of zt55, a novel indole derivative isolated from radix isatidis, using liquid chromatography/tandem mass and q-tof/tandem mass spectrometry
Current Pharmaceutical Analysis, ISSN: 1875-676X, Vol: 17, Issue: 2, Page: 210-221
2021
- 4Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures4
- Readers4
Article Description
Background: ZT55 is a novel natural product isolated from Radix isatidis. It is a highly-selective tyrosine kinase inhibitor against myeloproliferative neoplasms. Although earlier research has described the pharmacodynamic properties of ZT55 in vivo and in vitro, the quantitative determination and pharmacokinetic profile in vivo have not been thoroughly studied. Methods: A novel liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of ZT55 in rat plasma. A Waters symmetry C18 column was used for chromatographic separation; 0.1% formic acid in acetonitrile and 0.1% formic aqueous solu-tion was used as the mobile phase. Detection was performed by Multiple Reaction Monitoring (MRM) mode using electrospray ionization in the positive ion mode. UPLC-QTOF-MS was used for the identification of metabolites. Results: The method was linear (R=0.9988) over the concentration range of 1-2500 ng/mL. The lower limit of quantification was 1 ng/mL. The intra-day and inter-day precision of ZT55 showed a relative standard deviation within 8.47%, whereas the accuracy (RE) ranged from-4.84% to 4.45%. The recov-eries ranged from 92.89% to 97.21%. ZT55 reached the highest plasma concentration at 0.5h. The peak concentrations with three dosages were 103.59±10.11, 185.23±29.56, and 355.98±28.86 ng/mL. The AUC of three dosages were 874.70±72.33, 433.80±49.33, and 231.65±19.41 ng•h/ml respectively. Five metabolites of ZT55 from plasma were confirmed. The main pathways of ZT55 in vivo were hy-drolysis, N-dealkylation, glycosylation, and sulfonation. Conclusion: LC-MS/MS method was successfully applied to the pharmacokinetic study of ZT55 after oral administration and intravenous. ZT55 exhibited rapid oral absorption, high elimination, and low absolute bioavailability. This study provides important pharmacokinetic and metabolism information for further pharmacological and toxicological research on ZT55.
Bibliographic Details
Bentham Science Publishers Ltd.
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know